The Woodlands, TXNCT01409161Now EnrollingIRB Ready

Acute Promyelocytic Leukemia Clinical Trial in The Woodlands, TX

Access cutting-edge acute promyelocytic leukemia treatment through this clinical trial at a research site in The Woodlands. Study-provided care at no cost to qualified participants.

Sponsored by M.D. Anderson Cancer Center

Quick Self-Assessment

See if you qualify for this The Woodlands location

Preparing your pre-screening questions...

Expert Care in The Woodlands

Access acute promyelocytic leukemia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related acute promyelocytic leukemia treatment provided free

Apply for This The Woodlands Location

Check if you qualify for this acute promyelocytic leukemia clinical trial in The Woodlands, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to The Woodlands

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit The Woodlands site if eligible
  4. 4Begin participation

About This Acute Promyelocytic Leukemia Study in The Woodlands

This phase II trial studies how well tretinoin and arsenic trioxide with or without gemtuzumab ozogamicin works in treating patients with previously untreated acute promyelocytic leukemia. Drugs used in chemotherapy, such as tretinoin and arsenic trioxide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotoxins, such as gemtuzumab ozogamicin, may find certain cancer cells and kill the

Sponsor: M.D. Anderson Cancer Center

Who Can Participate

Inclusion Criteria

A diagnosis of APL based on the presence of the PML-RAR-alpha fusion gene by cytogenetics, polymerase chain reaction (PCR), or POD test
Ability to understand and the willingness to sign a written informed consent document indicating that they are aware of the investigational nature of the study
Patients in whom therapy for APL was initiated on an emergent basis are eligible (patients may have already started treatment with ATRA, ATO, and/or one dose of idarubicin due to the urgency to start therapy early)
Women of child-bearing potential must have a negative serum pregnancy test at screening; in addition to having a negative pregnancy test confirmed at screening, all female participants of childbearing potential must have a negative pregnancy test confirmed within 48 hours prior to dosing with the study drug
All sexually active subjects (males and females of child-bearing potential) agree to use 2 effective methods of contraception for the duration of the

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in The Woodlands?

Yes, this clinical trial (NCT01409161) has an active research site in The Woodlands, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Acute Promyelocytic Leukemia Treatment Options in The Woodlands, TX

If you're searching for acute promyelocytic leukemia treatment options in The Woodlands, TX, this clinical trial (NCT01409161) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our The Woodlands research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute promyelocytic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all acute promyelocytic leukemia clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in The Woodlands, TX

See all leukemia clinical trials recruiting in The Woodlands — not just this study.

Browse Leukemia Trials in The Woodlands

Ready to Join in The Woodlands?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · The Woodlands, TX